Leukemia Vonnie (a pseudonym) was injected in the hospital, "methotrexate", the double-leg paralysis and other adverse reactions. That the drug due to contamination after being identified as counterfeit Ministry of Health, hospitals and pharmaceutical companies Vonnie will be reported to the West Side Court, claims 957 million yuan, including 1 million yuan compensation for moral damage. Yesterday, the plaintiffs' lawyers said that the current Court has yet to apply for pharmaceutical companies to identify the decision made, the plaintiff in the court waiting for the second notification.
Patients with lower limb paralysis after injection
April 2007, 22-year-old Vonnie just to work on was diagnosed with leukemia, Vonnie's parents came to Beijing, a well-known hospital for treatment. According to Vonnie's family said the hospital several times for Vonnie injected by Shanghai Pharmaceutical (Group) Co.,amgKj1F50b, Ltd. Hualian Pharmaceutical Factory production of "methotrexate" Vonnie soon appeared numbness, paralysis of the lower limbs other adverse reactions.
"Before injecting the drug, Vonnie and family matching has been successful, will soon be a bone marrow transplant. Vonnie paralysis after surgery can not do." Vonnie's family said.
Ministry of Health and the State Food and Drug Administration investigation found the hospital used "methotrexate" is a multi-contaminated batch of counterfeit drugs. Vonnie's family believes that there is a certain responsibility for the hospital. On the issue of compensation, Vonnie's family said, in September 2007, the hospital has proposed a one-time compensation 690,000 yuan. Vonnie's family can not accept this amount, then filed a lawsuit to the West Side Court, claims 957 million yuan. Plaintiff lawyer told reporters, including one million yuan compensation for moral damage.
Responsibility for the hospital, said the court did not
The day before yesterday afternoon, the West Side Court hearing the case. Because of Hualian Pharmaceutical agent application "not open" trial, so the judge invited the media reporters to leave the courtroom.
After the trial, the defendant pharmaceutical companies and hospitals were not interviewed by reporters. Reporters yesterday several times to call the pharmaceutical companies, the phone has no answer. According to the plaintiff pleadings pharmaceutical companies show that after the incident the plant several times to communicate with Vonnie families, in the case of the identification procedures have not yet been confirmed, to reach a settlement, voluntary recognition of patients suffered a "methotrexate" drug damage, and would like to make specific and reasonable compensation package, but the end result of the other party asking price is too high,dh2whWO93g, reconciliation failed. Therefore ask the court to legally recognized pharmaceutical liability of the company.
Plaintiff lawyer told reporters that the respondent opinions hospital yes, Vonnie admission backyard party by treatment standard treatment for the purchase of drugs and equipment are from formal channels,jordan moins cher, hospital damage results Vonnie no responsibility.
The plaintiff waiting for the second trial
"Pharmaceuticals raised several identified in the trial, including whether Vonnie paralysis and 'methotrexate' causal relationship to make the identification, as well as disability rating Vonnie make the identification." Plaintiffs' lawyers say , the current court has yet to make a decision to apply for pharmaceutical companies make the identification, he and his family are waiting for Vonnie second court hearing notice.
According to proceedings in civil cases, the court will conduct the mediation of the plaintiff and defendant. Plaintiffs' lawyers, said: "The two sides is too large for the amount of compensation differences, it seems, the possibility of reconciliation is not too large."
Morning News reporter Wu Xin
Related Links
"Methotrexate" factory was canceled pharmaceutical production qualification
Methotrexate, is mainly used for acute leukemia, osteosarcoma and other cancer treatment. July and August 2007, the National Adverse Drug Reaction Monitoring Center received respectively in Shanghai, Beijing and other places of the report to reflect, some hospitals in the use of part of Shanghai Hualian Pharmaceutical lot intrathecal methotrexate and cytarabine after Some leukemia patients with walking difficulties and other symptoms of nerve damage. When the Ministry of Health and the State Food and Drug Administration to identify the pharmaceutical companies in the production of injection of methotrexate, resulting in multiple batches of medicines were contaminated,pXDhDpHTdS, resulting in hundreds of leukemia patients nationwide lower limb disability, is a major pharmaceutical production and quality responsibility for the accident. Shanghai Hualian Pharmaceutical drug production and therefore eligible to be revoked in accordance with law.
